DEDICATED TO RARE DISEASES Trademark

Trademark Overview

On Monday, May 17, 2010, a trademark application was filed for DEDICATED TO RARE DISEASES with the United States Patent and Trademark Office. The USPTO has given the DEDICATED TO RARE DISEASES trademark a serial number of 85040036. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 18, 2018. This trademark is owned by Synageva Biopharma Corp.. The DEDICATED TO RARE DISEASES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research and development concerning products and processes for the expression, evolution, screening, production and purification of proteins and other pharmaceutical compounds for research and industry
dedicated to rare diseases

General Information

Serial Number85040036
Word MarkDEDICATED TO RARE DISEASES
Filing DateMonday, May 17, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 18, 2018
Registration Number4039350
Registration DateTuesday, October 11, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2010

Trademark Statements

Disclaimer with Predetermined Text"RARE DISEASES"
Goods and Servicesscientific research and development concerning products and processes for the expression, evolution, screening, production and purification of proteins and other pharmaceutical compounds for research and industry

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 18, 2018
Primary Code042
First Use Anywhere DateTuesday, May 4, 2010
First Use In Commerce DateTuesday, May 4, 2010

Trademark Owner History

Party NameALEXION PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEW HAVEN, CT 06510
Party NameSynageva Biopharma Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameSynageva Biopharma Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAthens, GA 30605
Party NameSynageva Biopharma Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAthens, GA 30605

Trademark Events

Event DateEvent Description
Friday, May 18, 2018CANCELLED SEC. 8 (6-YR)
Tuesday, October 11, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 17, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, July 25, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 25, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 15, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 15, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 2, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 2, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 23, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 23, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2011REGISTERED-PRINCIPAL REGISTER
Friday, September 9, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 8, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, September 6, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 15, 2011STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 27, 2011USE AMENDMENT FILED
Monday, August 15, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 27, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, February 1, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2010PUBLISHED FOR OPPOSITION
Saturday, October 30, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, October 30, 2010ASSIGNED TO LIE
Monday, October 18, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 18, 2010EXAMINER'S AMENDMENT ENTERED
Monday, October 18, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 18, 2010EXAMINERS AMENDMENT E-MAILED
Monday, October 18, 2010EXAMINERS AMENDMENT -WRITTEN
Friday, September 3, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 3, 2010NON-FINAL ACTION E-MAILED
Friday, September 3, 2010NON-FINAL ACTION WRITTEN
Monday, August 30, 2010ASSIGNED TO EXAMINER
Thursday, May 20, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 20, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

diseases rare dedicated research proteins purification other compounds industry production pharmaceutical evolution concerning